Drug intelligence / Profile preview

HNP-2007

Development stage: Preclinical
Lead developer: Hana Pharmaceuticals
Modality: Small Molecules
Administration: Intravenous

Overview

HNP-2007 is a development-stage active pharmaceutical ingredient (API) being developed by Hana Pharm for use in general anesthesia. It is currently in the process development phase, focusing on the synthesis and manufacturing scale-up of the compound. Hana Pharm, a South Korean pharmaceutical company specializing in anesthetics and analgesics, includes HNP-2007 in its research pipeline alongside other anesthetic agents like remimazolam. The project is categorized under API development, suggesting a focus on manufacturing excellence for a specific anesthetic molecule.

Beyond the preview

Go deeper on HNP-2007.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HNP-2007.

Explore the full profile